Related Experiment Video
Updated: Jun 19, 2026

Study of Protein Dynamics via Neutron Spin Echo Spectroscopy
Published on: April 13, 2022
NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar
Alessandro Mascioni1, Franklin J Moy, Lisa K McNeil
1Wyeth Research, Structural Biology and Computational Chemistry, 200 Cambridge Park Drive, Cambridge, MA 02140, USA.
Abstract:
Neisseria meningitidis is a major cause of meningitis. Although protective vaccination is available against some pathogenic serogroups, serogroup B meningococci have been a challenge for vaccinologists. A family of outer membrane lipoproteins, LP2086 (or factor H binding proteins, fHbp), has been shown to elicit bactericidal antibodies and is currently part of a cocktail vaccine candidate. The NMR structure of the variant LP2086-B01 in micellar solution provided insights on the topology of this family of proteins on the biological membrane. Based on flow cytometry experiments on whole meningococcal cells, binding experiments with monoclonal antibodies, and the NMR structure in micellar solution, we previously proposed that LP2086-B01 anchors the outer bacterial membrane through its lipidated N-terminal cysteine, while a flexible 20 residue linker positions the protein above the layer of lipo-oligosaccharides that surrounds the bacteria. This topology was suggested to increase the antigen exposure to the immune system. In the present work, using micellar solution as a membrane mimicking system, we characterized the backbone dynamics of the variant LP2086-B01 in both its lipidated and unlipidated forms. In addition, binding experiments with a Fab fragment derived from the monoclonal MN86-1042-2 were also performed. Our data suggests that due to the length and flexibility of the N-terminal linker, the antigen is not in contact with the micelle, thus making both N- and C-domains highly available to the host immune system. This dynamic model, combined with the binding data obtained with MN86-1042-2, supports our previously proposed arrangement that LP2086-B01 exposes one face to the extracellular space. Binding of MN86-1042-2 antibody shows that the N-domain is the primary target of this monoclonal, providing further indication that this domain is immunologically important for this family of proteins.
Insights
Outer membrane protein LP2086-B01 from Neisseria meningitidis is key for vaccines. Its flexible structure enhances immune system access to critical antigen domains, improving vaccine potential against meningitis B.
Area of Science:
- Microbiology
- Structural Biology
- Immunology
Background:
- Neisseria meningitidis serogroup B poses a significant challenge for meningitis vaccines.
- Outer membrane lipoprotein LP2086 (factor H binding protein, fHbp) is a promising vaccine antigen.
- Previous studies proposed a model where LP2086's flexible linker enhances antigen exposure.
Purpose of the Study:
- To investigate the backbone dynamics of LP2086-B01 in lipidated and unlipidated forms.
- To characterize the interaction of LP2086-B01 with monoclonal antibody MN86-1042-2.
- To validate the proposed topology and antigen accessibility model of LP2086-B01.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to determine backbone dynamics in micellar solutions.
- Flow cytometry on whole meningococcal cells.
- Binding experiments using monoclonal antibody fragments (Fab).
Main Results:
- The N-terminal linker's flexibility prevents antigen contact with the bacterial membrane, ensuring domain availability.
- Both N- and C-domains of LP2086-B01 are highly accessible to the host immune system.
- The N-domain is the primary target for the MN86-1042-2 antibody, confirming its immunological importance.
Conclusions:
- LP2086-B01 exhibits a dynamic structure that optimizes antigen exposure for immune recognition.
- The proposed model of LP2086-B01 topology is supported, highlighting the N-domain's immunogenicity.
- These findings reinforce LP2086 as a critical target for developing effective vaccines against Neisseria meningitidis serogroup B.
